Literature DB >> 15448075

The Profile of Multiple Language Proficiencies: A Measure for Evaluating Language Samples of Deaf Children.

Gayle Goldstein1, James M. Bebko.   

Abstract

This article reports the process of creating a developmental measure that assesses the multilingual capabilities of deaf children and the problems that were encountered. Because deaf children may be using more than one method of communication (e.g., sign language skills and spoken language skills), it is important to evaluate their skills as completely as possible. In a pilot study, we used a nominal scale that assessed language skills based on a single continuum, with good English and good American Sign Language (ASL) skills as its two extremes and approximately equal skills in both as the midpoint. In the main study, a more complete measure was created, the Profile of Multiple Language Proficiencies (PMLP). The PMLP uses a single scale that represents the different stages of language development that can be observed in both English and ASL. The PMLP showed reasonable initial reliability and has good promise as an easy-to-use measure of developing language skills in children who use multiple modalities of communication. Using the PMLP as a prototype, we discuss some of the issues that influence the reliability and validity in evaluating such a scale and how these can be overcome or avoided.

Entities:  

Year:  2003        PMID: 15448075     DOI: 10.1093/deafed/eng027

Source DB:  PubMed          Journal:  J Deaf Stud Deaf Educ        ISSN: 1081-4159


  2 in total

1.  Communicative deficits associated with maladaptive behavior in individuals with deafness and special needs.

Authors:  Johannes Fellinger; Magdalena Dall; Christoph Weber; Daniel Holzinger
Journal:  Front Psychiatry       Date:  2022-07-29       Impact factor: 5.435

2.  Development of a Social Communication Questionnaire (QSC-ID) for People With Intellectual Disability in a Deaf Sample: A Pilot and Feasibility Study.

Authors:  Chantal Weber; Christoph Weber; Johannes Fellinger; Daniel Holzinger
Journal:  Front Psychiatry       Date:  2021-12-08       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.